Please confirm you are a member of the intended audience
Yes, I am a healthcare professional based in Ireland
No, I am a patient who has been prescribed mavacamten OR a member of the general public based in Ireland
▼This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions via HPRA Pharmacovigilance at www.hpra.ie. Adverse reactions should also be reported to Bristol-Myers Squibb Medical Information on 1 800 749 749 or medical.information@bms.com.
.svg)